Table of Content


Chapter 1   Methodology and Scope
1.1    Market scope and definition
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates and calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Increasing prevalence of ulcerative colitis
3.2.1.2    Expanding treatment options
3.2.1.3    Increasing awareness and diagnosis
3.2.2    Industry pitfalls and challenges
3.2.2.1    High treatment costs
3.2.2.2    Side effects and safety concerns
3.3    Growth potential analysis
3.4    Regulatory landscape
3.5    Pipeline analysis
3.6    Porter’s analysis
3.7    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company matrix analysis
4.3    Competitive analysis of major market players
4.4    Competitive positioning matrix
4.5    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Drug Type, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Aminosalicylates
5.3    Biologics
5.4    Corticosteroids
5.5    Janus kinase (JAK) inhibitors
5.6    Immunosuppressants
5.7    Other drug types
Chapter 6   Market Estimates and Forecast, By Disease Type, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Proctosigmoiditis
6.3    Ulcerative proctitis
6.4    Left-sided colitis
6.5    Pancolitis or universal colitis
6.6    Fulminant colitis
Chapter 7   Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Oral
7.3    Injectable
Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Hospital pharmacies
8.3    Retail pharmacies
8.4    Online pharmacies
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Italy
9.3.5    Spain
9.3.6    Netherlands
9.4    Asia Pacific
9.4.1    China
9.4.2    Japan
9.4.3    India
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    South Africa
9.6.2    Saudi Arabia
9.6.3    UAE
Chapter 10   Company Profiles
10.1    AbbVie
10.2    Bausch Health Companies
10.3    Bristol Myers Squibb
10.4    Eli Lilly and Company
10.5    Johnson & Johnson
10.6    Merck
10.7    Mitsubishi Tanabe Pharma Corporation
10.8    Novartis
10.9    Pfizer
10.10    Sun Pharmaceutical Industries
10.11    Takeda Pharmaceutical Company Limited
10.12    Teva Pharmaceutical Industries